AbbVie Inc. is 283.0x more valuable than Harrow, Inc. by market capitalization ($397.12 B vs $1.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HROW | ABBV |
|---|---|---|
| Market cap | $1.40 B | $397.12 B |
| US-listed rank | #2394 | #30 |
| Revenue (latest FY) | $272.30M | $61.16B |
| Net income (latest FY) | -$5.14M | $4.23B |
| Net margin | -1.9% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 849 | 1,008 |
AbbVie Inc. is 283.0x more valuable than Harrow, Inc. by market capitalization ($397.12 B vs $1.40 B).
In their latest fiscal years, Harrow, Inc. reported $272.30M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Harrow, Inc. and AbbVie Inc., or browse the full rankings.